Bioorthogonal chemistry based on-demand drug delivery system in cancer therapy  

作　　者：Lan Lin Lai Jiang En Ren Gang Liu 

机构地区：[1]State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics&Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China

出　　处：《Frontiers of Chemical Science and Engineering》2023年第4期483-489,共7页化学科学与工程前沿（英文版）

基　　金：supported by the Major State Basic Research Development Program of China (Grant No.2017YFA0205201);the National Natural Science Foundation of China (Grant Nos.81925019 and U1705281).

摘　　要：Benefiting from the advantage of taking place in biological environments without interfering with an innate biochemical process,the bioorthogonal reaction that commonly contains the“bond formation”and“bond cleavage”system has been widely used in targeted therapy for a variety of tumors.Herein,several prominent cases based on the bioorthogonal reaction that tailoring the metabolic glycoengineering tactics to modified cells for cancer immunotherapy,and the innovative tactics for reducing the metal ions’toxic and side effects with microneedle patches will be highlighted.Based on these applications,the complexities,potential pitfalls,and opportunities of bioorthogonal chemistry in future cancer therapy will be evaluated.

关 键 词：bioorthogonal reaction cancer therapy metabolic glycoengineering bioorthogonal catalytic patch 

分 类 号：TQ460.4[化学工程—制药化工] R73[医药卫生—肿瘤]